<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="editorial"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Bone Res</journal-id><journal-id journal-id-type="iso-abbrev">Bone Res</journal-id><journal-title-group><journal-title>Bone Research</journal-title></journal-title-group><issn pub-type="ppub">2095-4700</issn><issn pub-type="epub">2095-6231</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30510840</article-id><article-id pub-id-type="pmc">6255775</article-id><article-id pub-id-type="publisher-id">40</article-id><article-id pub-id-type="doi">10.1038/s41413-018-0040-9</article-id><article-categories><subj-group subj-group-type="heading"><subject>Comment</subject></subj-group></article-categories><title-group><article-title>RANKL-RANK signaling regulates osteoblast differentiation and bone formation</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Cao</surname><given-names>Xu</given-names></name><address><email>xcao11@jhmi.edu</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2171 9311</institution-id><institution-id institution-id-type="GRID">grid.21107.35</institution-id><institution>Department of Orthopedic Surgery, </institution><institution>Johns Hopkins University School of Medicine, Ross Building, Room 229, </institution></institution-wrap>720 Rutland Ave, Baltimore, MD 21205 USA </aff></contrib-group><pub-date pub-type="epub"><day>27</day><month>11</month><year>2018</year></pub-date><pub-date pub-type="pmc-release"><day>27</day><month>11</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>6</volume><elocation-id>35</elocation-id><history><date date-type="received"><day>25</day><month>10</month><year>2018</year></date><date date-type="accepted"><day>4</day><month>11</month><year>2018</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2018</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2018</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p id="Par1">In the recent two decades, it has been well elucidated that receptor activator of nuclear factor-&#x003ba;B ligand (RANKL; also known as TNFSF11) binding to its receptor RANK (also known as TNFRSF11A) drives osteoclast development as the crucial signaling pathway.<sup><xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR3">3</xref></sup> However, accumulating evidence also implies that osteoblastic RANKL regulates osteoblastogenesis.<sup><xref ref-type="bibr" rid="CR4">4</xref>&#x02013;<xref ref-type="bibr" rid="CR6">6</xref></sup> The studies &#x0201c;RANKL signaling in bone marrow mesenchymal stem cells negatively regulates osteoblastic bone formation&#x0201d; by Chen et al. in the current issue of <italic>Bone Research</italic>, and &#x0201c;Coupling of bone resorption and formation by RANKL reverse signalling&#x0201d; by Yuki Ikeuchi et al. in <italic>Nature</italic> (2018;561:195&#x02013;200) reveal that RANKL-RANK signaling regulates osteoblastogenesis in addition to its role in osteoclastogenesis.</p><p id="Par2">Chen et al. demonstrate that RANK is expressed in bone marrow mesenchymal stem cells (BMSCs) and is decreased during osteogenic differentiation. RANK silencing significantly promotes, while overexpression suppresses, the osteoblast differentiation of BMSCs in vitro. Mice with a conditional knock-out of RANK in MSCs (Prx1-Cre: RANK<sup>flox/flox</sup>) show a significant increase of osteoblast differentiation and bone formation. Interestingly, in an ovariectomized mouse model, RANK conditional knock-out mice exhibit resistance to ovariectomy-induced bone loss relative to the sham-operated mice. This study reveals that RANKL forward signaling in BMSCs functions as a negative regulator in osteoblast differentiation and bone formation (Fig. <xref rid="Fig1" ref-type="fig">1</xref>).</p><p id="Par3">RANKL belongs to the tumor necrosis factor family and its bidirectional signaling has been indicated.<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR7">7</xref></sup> The most recent study by Yuki Ikeuchi et al. provided evidence for RANKL reverse signaling in the coupling of bone resorption and formation.<sup><xref ref-type="bibr" rid="CR8">8</xref></sup> RANK in small extracellular vesicles, secreted from the maturing osteoclasts, binds osteoblastic RANKL and promotes osteoblast differentiation by triggering RANKL reverse signaling, which activates runt-related transcription factor 2 (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). In vivo, the authors also establish a mouse model (RANKL<sup>P29A</sup>) to inhibit RANKL reverse signaling but not forward signaling. Bone formation is disrupted in RANKL<sup>P29A</sup> mice compared with wild-type mice after recombinant RANKL is administered. At last, the authors show that targeting RANKL reverse signaling prevents decreased bone formation by compensating for the shortage of coupling signals. The results suggest that RANKL reverse signaling is involved in the bone formation as a potential pharmacological target.</p><p id="Par4">These two studies convincingly demonstrate the functions of RANKL-RANK forward and reverse signaling in the regulation of osteoblast differentiation and bone formation. Chen et al. show that RANKL binds to RANK and inhibits osteoblastogenesis, while Yuki et al. demonstrate that vesicular RANK from maturing osteoclasts promotes osteoblastogenesis for the bone formation through RANKL reverse signaling. Specifically, RANKL forward signaling activates NF-&#x003ba;B for degradation of &#x003b2;-catenin. In RANKL reverse signaling, a proline-rich motif in the RANKL cytoplasmic tail interacts with Src homology 3 domains and activates PI3K.</p><p id="Par5">In summary, these two reports provide evidence that RANKL-RANK forward and reverse signaling regulates osteoblast differentiation and bone formation. The forward signaling inhibits osteogenic differentiation and the reverse signaling promotes osteoblast differentiation for bone formation (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Not only do the findings discover the novel regulatory roles of RANKL-RANK signaling in osteoblastogenesis but also they provide a potential pharmacological target in an anabolic therapy.<fig id="Fig1"><label>Fig. 1</label><caption><p>Mechanism of RANKL signaling in osteoblast differentiation. RANKL signaling drives osteoclastogenesis. In BMSCs, RANKL binding to RANK activates RANKL forward signaling, which inhibits osteoblast differentiation. Maturing osteoclasts secrete vesicular RANK which activates RANKL reverse signaling in osteoblasts and promotes osteoblast differentiation. During osteoblastogenesis, the RANK expression is reduced and RANKL forward signaling on osteoblast differentiation is relieved</p></caption><graphic xlink:href="41413_2018_40_Figa_HTML" id="d29e232"/></fig></p></body><back><notes notes-type="COI-statement"><sec id="FPar1"><title>Competing interests</title><p>The authors declare no competing interests.</p></sec></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lacey</surname><given-names>DL</given-names></name><etal/></person-group><article-title>Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation</article-title><source>Cell</source><year>1998</year><volume>93</volume><fpage>165</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81569-X</pub-id><pub-id pub-id-type="pmid">9568710</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>YY</given-names></name><etal/></person-group><article-title>OPGL is a key regulator of osteoclastogenesis, lymphocyte development, and lymph-node organogenesis</article-title><source>Nature</source><year>1999</year><volume>397</volume><fpage>315</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1038/16852</pub-id><pub-id pub-id-type="pmid">9950424</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><etal/></person-group><article-title>RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><year>2000</year><volume>97</volume><fpage>1566</fpage><lpage>1571</lpage><pub-id pub-id-type="doi">10.1073/pnas.97.4.1566</pub-id><pub-id pub-id-type="pmid">10677500</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otsuki</surname><given-names>Y</given-names></name><etal/></person-group><article-title>W9 peptide enhanced osteogenic differentiation of human adipose-derived stem cells</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2018</year><volume>495</volume><fpage>904</fpage><lpage>910</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2017.11.056</pub-id><pub-id pub-id-type="pmid">29154826</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uehara</surname><given-names>T</given-names></name><etal/></person-group><article-title>Delivery of RANKL-binding peptide OP3-4 promotes BMP-2-induced maxillary bone regeneration</article-title><source>J. Dent. Res.</source><year>2016</year><volume>95</volume><fpage>665</fpage><lpage>672</lpage><pub-id pub-id-type="doi">10.1177/0022034516633170</pub-id><pub-id pub-id-type="pmid">27006466</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Portal-Nunez</surname><given-names>S</given-names></name><etal/></person-group><article-title>Unexpected bone formation produced by RANKL</article-title><source>Trends Endocrinol. Metab.: TEM</source><year>2017</year><volume>28</volume><fpage>695</fpage><lpage>704</lpage><pub-id pub-id-type="doi">10.1016/j.tem.2017.06.003</pub-id><pub-id pub-id-type="pmid">28733136</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furuya</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Stimulation of bone formation in cortical bone of mice treated with a receptor activator of nuclear factor-kappaB ligand (RANKL)-binding peptide that possesses osteoclastogenesis inhibitory activity</article-title><source>J. Biol. Chem.</source><year>2013</year><volume>288</volume><fpage>5562</fpage><lpage>5571</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.426080</pub-id><pub-id pub-id-type="pmid">23319583</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikebuchi</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Coupling of bone resorption and formation by RANKL reverse signalling</article-title><source>Nature</source><year>2018</year><volume>561</volume><fpage>195</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1038/s41586-018-0482-7</pub-id><pub-id pub-id-type="pmid">30185903</pub-id></element-citation></ref></ref-list></back></article>